## Communicated by Sesgio Otrdenghi Alport's syndrome is characterized clinically by a nonimmune glomerulopathy, often accompanied by sensorineural hearing loss and lens abnormalities, frequently due to mutations in the COL4A5 gene.
โฆ LIBER โฆ
Differential splicing of COL4A5 mRNA in kidney and white blood cells: A complex mutation in the COL4A5 gene of an alport patient deletes the NC1 domain
โ Scribed by Caiying Guo; Boudewijn Damme; Rita Damme-Lombaerts; Herman Berghe; Jean-Jacques Cassiman; Peter Marynen
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 110 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Deletion spanning the 5โฒ ends of both th
โ
Alessandra Renieri; Maria Teresa Bassi; Lucia Galli; Jing Zhou; Marisa Giani; Ma
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 290 KB
Detection of 12 novel mutations in the c
โ
Eileen Boye; Frances Flinter; Jing Zhou; Karl Tryggvason; Martin Bobrow; Ann Har
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 1019 KB
A population of 35 Alport syndrome patients, defined by strict diagnostic criteria, was screened for mutations in 23 exons of the COL4A5 gene by SSCP analysis. Mobility shifts were observed in 12 out of 35 patients and were shown to represent genuine mutations. 9 of these were glycine substitutions